Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer
Open Access
- 1 July 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 6 (3) , 236-246
- https://doi.org/10.1215/s1152851703000668
Abstract
We conducted a phase 1 study of 9 pediatric patients with recurrent brain tumors using monocyte-derived dendritic cells pulsed with tumor RNA to prodKeywords
This publication has 20 references indexed in Scilit:
- Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.2003
- Unarmed, tumor-specific monoclonal antibody effectively treats brain tumorsProceedings of the National Academy of Sciences, 2000
- Dendritic cells: Immunological sentinels with a central role in health and diseaseImmunology & Cell Biology, 2000
- Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopesJournal of Clinical Investigation, 2000
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1995
- Recent advances in immunobiology of brain tumorsJournal of Neuro-Oncology, 1993
- “In vitro” effect of interleukin-1 beta on human glioma cell lines: regulation of cell proliferation and IL-6 productionImmunology Letters, 1992
- ELISA for the routine determination of antitoxic immunity to tetanusJournal of Biological Standardization, 1986
- CONDITIONS DETERMINING THE TRANSPLANTABILITY OF TISSUES IN THE BRAINThe Journal of Experimental Medicine, 1923